Metraipolis › archive › dc_d7af075ec53b

Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients — Europe PMC PMID:40916717

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40916717
DOI
10.1017/s003329172510161x
License (as archived)
solo-consultazione
Archived
2026-11-10T02:16:44.265Z
SHA-256 of the archived text
0f29f135780f662f9544c869e22fcca78c27b4458dffd8304dfbddab123febcb
Stable URL of this page
https://metraipolis.com/documento/dc_d7af075ec53b

How to cite

Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients — Europe PMC PMID:40916717 — Europe PMC (en), https://europepmc.org/article/MED/40916717 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7af075ec53b (Metraipolis archive dc_d7af075ec53b, sha256 0f29f135780f662f9544c869e22fcca78c27b4458dffd8304dfbddab123febcb)
BibTeX
@misc{dcd7af075ec53b,
  title = {Dopamine D2/3R availability after discontinuation of antipsychotic treatment: a [11C]raclopride PET study in remitted first-episode psychosis patients — Europe PMC PMID:40916717},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40916717},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7af075ec53b; sha256 0f29f135780f662f9544c869e22fcca78c27b4458dffd8304dfbddab123febcb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40916717. Agents can read the archived copy with the MCP tool read_document.